This Mesoblast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
Take Stock Of The Week Ahead

Get all the latest Share Market trends and news to set you up for the week ahead.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Jefferies analyst David Stanton downgraded the rating for Mesoblast Limited MESO from Buy to Hold. Mesoblast shares closed at $14.63 on Friday. See how other analysts view this stock.
  • William Blair analyst Sami Corwin downgraded Applied Therapeutics, Inc. APLT from Outperform to Market Perform. Applied Therapeutics shares closed at $0.8801 on Friday. See how other analysts view this stock.
  • BTIG analyst Thomas Catherwood downgraded the rating for Innovative Industrial Properties, Inc. IIPR from Buy to Neutral. NCR Atleos shares closed at $73.66 on Friday. See how other analysts view this stock.

Considering buying MESO stock? Here’s what analysts think:

Read This Next:

Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm